Signaling pathways
-
BA8970 BPR1K871Summary: BPR1K871 (DBPR114) is a potent and selective dual inhibitor. - BA8971 FLT3-IN-19Summary: FLT3-IN-19 is a potent and selective inhibitor.
- BA8972 FLT3-IN-10Summary: FLT3-IN-10 is a potent inhibitor of FMS-like tyrosine kinase 3.
- BA8973 UNC4203Summary: UNC4203 is a potent, orally active and highly selective inhibitor.
- BA8974 FLT3-IN-16Summary: FLT3-IN-16 is a potent inhibitor.
- BA8975 BT18Summary: BT18 is a molecular analog that functions like glial cell-derived neurotrophic factor (GDNF).
- BA8976 DusigitumabSummary: Dusigitumab (MEDI573) is a human IgG2λ monoclonal antibody.
- BA8977 VeligrotugSummary: An IgG1-kappa, anti-(insulin-like growth factor 1 receptor, CD221) chimeric monoclonal antibody.
- BA8979 AGL-2263Summary: Inhibitors of insulin receptors and insulin-like growth factor receptors.
- BA8980 MID-1Summary: MID-1 is an inhibitor of (Mitsugumin53-insulin receptor substrate 1) interaction.